I am/have/had
I am looking for
Advanced Filters
Found 494 clinical trials
Featured trial
Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL
The purpose of this study is to explore the efficacy and safety of Inotuzumab Ozogamicin in the treatment of minimal residual disease recurrence after HSCT of ALL patients.
- 0 views
- 16 Mar, 2026
- 2 locations
